"The Estimated Effect of Oral Contraceptive Use on the Cumulative Risk of Epithelial Ovarian Cancer."

Abstract

Listen

Translate article

This study sought to determine the effect of oral contraceptive (OC) use on the cumulative incidence of epithelial ovarian cancer from ages 20 to 40 20 to 50m and 20 to 55 years among 4 groups of women: positive family history negative family history parous and nulliparous. Cancer and Steroid Hormone Study data were combined with data from the Surveillance Epidemiology and End Results Network to provide estimates of the age-specific incidence rates of epithelial ovarian cancer among never-users of OCs in the 4 specified groups of women. These rates provided the basis for calculating cumulative incidences. The rates in women using OCs were estimated from meta-analysis of the epidemiologic literature using regression equations expressing the log-relative rate of epithelial ovarian cancer as a function of duration of use and recency. In all 4 groups the cumulative number of epithelial ovarian cancer cases estimated to occur per 100000 OC users compared to never-users decreased with increasing duration of OC use. The authors results suggest that 5 years of OC use by nulliparous women can reduce their ovarian cancer risk to the level seen in parous women who never use OCs and that 10 years of OC use by women with a positive family history can reduce their risk to a level below that for women whose family history is negative and who never use OCs. These data represent the first published estimates of the effect of OC use on the cumulative incidence of epithelial ovarian cancer by family history and by parity. The demonstrated substantial noncontraceptive benefit from OCs justifies their judicious use as a potentially powerful resource for primary prevention in women at high risk of ovarian cancer. (authors)